Skip to Main Content

Author Details

Zaid Taha
Ottawa Hospital Research Institute, University of Ottawa
2018
21
9
PMIDPaper TitleJournal TitlePublished Year
36713447CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.Front Immunol2023
37822719A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.Mol Ther Methods Clin Dev2023
37766429Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVο51 oncolytic virotherapy.Mol Ther2023
37153626Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus.Front Immunol2023
37242495Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.Pharmaceuticals (Basel)2023
34687845Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.Mol Ther2022
35740500A New Functional Screening Platform Identifies Colistin Sulfate as an Enhancer of Natural Killer Cell Cytotoxicity.Cancers (Basel)2022
35393414Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.Nat Commun2022
35526097Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.Mol Ther2022
36405739Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.Front Immunol2022
36532027Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines.Front Immunol2022
34658235Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern.ACS Infect Dis2021
33706157SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition.Biosens Bioelectron2021
33668756Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.Int J Mol Sci2021
33578036Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.Mol Ther2021
32444806The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.Commun Biol2020
32872641Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.Membranes (Basel)2020
30717267PI3k and Stat3: Oncogenes that are Required for Gap Junctional, Intercellular Communication.Cancers (Basel)2019
31177110Regulation of Differentiation of HC11 Mouse Breast Epithelial Cells by the Signal Transducer and Activator of Transcription-3.Anticancer Res2019
30986357Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cells.Biochem Cell Biol2019
29597279The Hippo Pathway: Immunity and Cancer.Cancers (Basel)2018
  • 1 - 21 of 21

Recommended Authors

University of California San Francisco
Career Start Year 2017
Number of shared co-authors 0
New York University Grossman School of Medicine
Career Start Year 2014
Number of shared co-authors 0
J. David Gladstone Institutes
Career Start Year 2014
Number of shared co-authors 2
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Yale University
Career Start Year 2012
Number of shared co-authors 0
University of California berkeley
Career Start Year 2011
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 0
Laura and Isaac Perlmutter Cancer Center
Career Start Year 2007
Number of shared co-authors 1
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2006
Number of shared co-authors 0
Foundation for the National Institutes of Health
Career Start Year 2004
Number of shared co-authors 0
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 1
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2001
Number of shared co-authors 0
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 0
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 2
National Cancer Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
University of California San Diego
Career Start Year 1994
Number of shared co-authors 0
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 0
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 1
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 0

Collaborators

Ottawa Hospital Research Institute, University of Ottawa
Co-authored papers 17
Ottawa Hospital Research Institute
Co-authored papers 12
Ottawa Hospital Research Institute
Co-authored papers 12
Ottawa Hospital Research Institute
Co-authored papers 12
Cancer Research Institute, Queen's University
Co-authored papers 11
Ottawa Hospital Research Institute
Co-authored papers 10
Ottawa Hospital Research Institute
Co-authored papers 7
Ottawa Hospital Research Institute
Co-authored papers 7
University of Ottawa
Co-authored papers 6
Ottawa Hospital Research Institute
Co-authored papers 5
Ottawa Hospital Research Institute
Co-authored papers 4
Ottawa Hospital Research Institute, The Ottawa Hospital
Co-authored papers 4
The Ottawa Hospital Research Institute
Co-authored papers 4
Ottawa Hospital Research Institute
Co-authored papers 2
Ottawa Hospital Research Institute, The Ottawa Hospital
Co-authored papers 2
University of Ottawa Heart Institute
Co-authored papers 1
Centre de Recherche du Centre Hospitalier de l'Universite de Montreal
Co-authored papers 1
Ottawa Hospital Research Institute
Co-authored papers 1
Ottawa Hospital Research Institute
Co-authored papers 1
The Ottawa Hospital/University of Ottawa
Co-authored papers 1
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 1
The Institute of Cancer Research
Co-authored papers 1
Leeds Institute of Medical Research at St James's, University of Leeds
Co-authored papers 1
Ottawa Hospital Research Institute
Co-authored papers 1
University of Ottawa
Co-authored papers 1
Ottawa Hospital Research Institute
Co-authored papers 1
Ottawa Hospital Research Institute
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Ottawa Hospital Research Institute
Co-authored papers 1
The Ottawa Hospital
Co-authored papers 1